Invention Grant
- Patent Title: Deuterated derivatives of ruxolitinib
- Patent Title (中): 鲁索替尼的氘代衍生物
-
Application No.: US14707912Application Date: 2015-05-08
-
Publication No.: US09249149B2Publication Date: 2016-02-02
- Inventor: I. Robert Silverman , Julie F. Liu , Adam J. Morgan , Bhaumik Pandya , Scott L. Harbeson
- Applicant: Concert Pharmaceuticals, Inc.
- Applicant Address: US MA Lexington
- Assignee: Concert Pharmaceuticals, Inc.
- Current Assignee: Concert Pharmaceuticals, Inc.
- Current Assignee Address: US MA Lexington
- Agency: Foley Hoag LLP
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/519 ; A61K45/06 ; A61P35/00
Abstract:
The present invention in one embodiment provides a compound of Formula A: or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising the compound; and methods of treating the indications disclosed herein.
Public/Granted literature
- US20150239896A1 Deuterated Derivatives of Ruxolitinib Public/Granted day:2015-08-27
Information query
